Access Guide · Updated November 2026

Compounding Pharmacy Shut Down? Where to Go Next

If your compounding pharmacy just closed, stopped filling GLP-1 prescriptions, or sent you an email saying they can no longer supply your compounded semaglutide or tirzepatide, you are not alone. Since the FDA declared the semaglutide and tirzepatide shortages over, compounders have faced tighter limits and more legal pressure, and some have stopped making these drugs. I have tracked 54+ telehealth providers and their pharmacy networks over the past year. Here is exactly what to do, starting today.

Do Not Panic: Your Prescription Is Still Valid

The first thing to understand is that your prescription does not expire just because the pharmacy closed. A prescription is written by your provider, not your pharmacy. If your compounding pharmacy shuts down, you still have an active prescription from the clinician who wrote it.

What this means in practice:

Your provider can transfer your prescription to a different compounding pharmacy or write a new one for a brand-name medication.
You are not starting over. You do not need a new consultation, new bloodwork, or a new diagnosis. Your medical records and treatment history belong to you and your provider.
Check how much you have left. Count your remaining doses so you know how much time you have to find your next option.

The worst thing you can do right now is let treatment lapse without a plan. An unplanned gap can mean returning hunger and may mean restarting at a lower dose. For example, the Wegovy label says that if 2 or more consecutive weekly doses are missed, dose escalation should restart at a lower dose to reduce stomach and gut side effects.

Why Compounding Pharmacies Are Closing

Here is the short version of what happened.

Semaglutide and tirzepatide were placed on the FDA shortage list in 2022. That gave compounders much more room to make copies under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act. According to the FDA’s policy page for compounders, the FDA declared the tirzepatide shortage resolved on October 2, 2024 (confirmed December 19, 2024) and the semaglutide shortage resolved on February 21, 2025. Its grace periods for compounders ended in March 2025 for tirzepatide and by May 22, 2025 for semaglutide.

Novo Nordisk and Eli Lilly have also sued many compounders, med spas, and telehealth sellers, and the FDA has sent warning letters over compounded GLP-1 marketing. Some pharmacies stopped compounding GLP-1s rather than fight.

The result: some patients who relied on cheaper compounded GLP-1s are suddenly without a source. If you want the full breakdown of how compounded and brand-name medications compare, our compounded vs brand-name guide covers the legal and quality differences in detail.

Your Three Options Right Now

You have three realistic paths forward. Each has different cost, speed, and availability tradeoffs.

Option 1: Switch to Another Compounding Pharmacy

Some telehealth providers still sell compounded GLP-1s. Under the FDA’s current policy, 503B outsourcing facilities cannot make semaglutide or tirzepatide copies from bulk ingredient, because neither drug is on the shortage list or the 503B bulks list. 503A pharmacies can still compound for an individual patient within limits, such as when a prescriber documents a significant difference from the approved product.

What to expect:

Cost: varies by provider and dose, and changes often
Availability: varies, and this path carries the most risk of another disruption

The key question to ask any new provider: “Which pharmacy do you use, and are they currently filling compounded semaglutide/tirzepatide orders?” Get a specific answer, not a vague reassurance.

Option 2: Switch to Brand-Name Medication

If you want to avoid compounding uncertainty entirely, switching to a brand-name GLP-1 is the most stable path. Brand-name medications from Novo Nordisk (Ozempic, Wegovy) and Eli Lilly (Mounjaro, Zepbound) are not affected by the compounding crackdown.

What to expect:

Cost without insurance: manufacturer self-pay programs start at $149 a month for the Wegovy pill and $299 a month for the lowest Zepbound dose (see table below)
Availability: the FDA has declared the semaglutide and tirzepatide injection shortages resolved

Brand-name self-pay pricing has come down a lot since 2024. Our cheapest GLP-1 guide covers every discount pathway in detail.

Option 3: Use a Telehealth Provider That Handles Transitions

Several telehealth platforms have built their model around pharmacy flexibility. They work with multiple pharmacies (both compounding and retail) and can switch you between them if one goes down. This is the option I would pursue first if my pharmacy closed tomorrow.

Price Comparison: Your Real Costs by Path

Brand-name self-pay prices as of Nov 4, 2026:

Path	Monthly Cost	Source
Wegovy pen	$349 for all doses up to 2.4 mg ($199 for the first 2 fills of the two lowest doses for new patients through Dec 31, 2026)	NovoCare Pharmacy
Wegovy pill	$149 to $299 depending on dose	NovoCare Pharmacy
Ozempic pen	$349 for 0.25 mg to 1 mg, $499 for 2 mg	NovoCare Pharmacy
Zepbound vial or KwikPen	$299 for 2.5 mg, $399 for 5 mg, $449 for 7.5 mg to 15 mg if refilled within 45 days	LillyDirect
Compounded GLP-1 (new source)	Varies	If you can find an active, legitimate source
Brand with insurance	Depends on plan	Coverage for weight loss varies widely

Wegovy and Zepbound are FDA-approved for chronic weight management. Ozempic and Mounjaro are approved for type 2 diabetes, so weight loss use is off-label.

If cost is the deciding factor, check whether you qualify for manufacturer savings programs, copay cards, or patient assistance programs. You can also check our insurance coverage guide if you have employer or marketplace insurance that might cover GLP-1s.

Compare GLP-1 providers that handle pharmacy transitions

Browse Provider Directory →

Telehealth Providers That Offer Pharmacy Flexibility

Not every telehealth provider is set up to handle a pharmacy switch. Some are locked to a single compounding partner, which means if that partner goes down, you are stuck. Others work with multiple pharmacies and can pivot quickly.

Our provider directory lists which platforms offer compounded options, brand-name options, or both. Prices and pharmacy partners change often, so confirm directly with the provider.

When evaluating a new provider, ask these specific questions:

Which pharmacy fills your compounded prescriptions? Get the actual pharmacy name, not just “our pharmacy partner.”
What happens if that pharmacy stops compounding? Do they have backup pharmacies?
Can you prescribe brand-name as a fallback? Some compounding-only providers cannot or will not switch you to brand-name.
How fast can you ship? If you are running low, a 2-week turnaround is too long.

How to Switch Providers Without a Treatment Gap

The biggest risk when your pharmacy closes is a gap in treatment. Here is a step-by-step process to minimize that risk.

Step 1: Check your current supply. Count how many doses you have left. This determines your urgency. If you have 4+ weeks, you have time to be selective. If you have less than 2 weeks, prioritize speed over cost.

Step 2: Contact your current prescribing provider. Ask them to transfer your prescription to a new pharmacy or send you your medical records so a new provider can pick up where you left off. Most telehealth providers will cooperate with this, though some make it unnecessarily difficult.

Step 3: Sign up with a new provider. If your current provider cannot find you a new pharmacy, switch providers entirely. Be upfront that you are an existing patient transferring, not a new patient. This often speeds things up.

Step 4: Confirm the pharmacy is actively filling orders. Before you pay, ask the new provider to confirm their pharmacy is currently shipping the medication you need. “We work with a compounding pharmacy” is not the same as “our pharmacy shipped 500 orders last week.”

Step 5: Request overlapping supply if possible. Some providers will expedite shipping for patients transferring from a closed pharmacy. Ask about rush delivery or overnight options. The small extra cost is worth avoiding a treatment gap.

If you have had a gap, do not restart at your old dose on your own. Ask your prescriber whether to restart at a lower dose. Our Mounjaro dosage guide covers the standard dose steps.

The Legal Reality in 2026

Compounded semaglutide: The FDA declared the shortage resolved on February 21, 2025. Large-scale copying is no longer permitted, and Novo Nordisk has sued many sellers.

Compounded tirzepatide: The FDA declared the shortage resolved on October 2, 2024, and a federal court upheld that decision in May 2025. No tirzepatide formulation is on the shortage list. Eli Lilly has also sued compounders and sellers.

What this means for you: Some patient-specific compounding continues under 503A, but supply is less reliable than it was in 2024. If you choose the compounding path, have a backup plan. Know which brand-name option you would switch to and what it would cost.

For the full legal breakdown, our compounded vs brand-name guide stays updated as the situation evolves.

What I Would Do

I am on Mounjaro (brand-name) through my prescribing provider, so this particular issue does not affect me directly. But if I were on compounded tirzepatide and my pharmacy shut down tomorrow, here is my exact plan:

Same day: Contact my provider and ask them to either transfer my prescription to a new compounding pharmacy or write a brand-name prescription as a bridge.
Within 48 hours: Sign up with a telehealth provider that works with multiple pharmacies (Ro, Hims, or Found based on current availability).
While waiting for new supply: Check LillyDirect self-pay pricing for Zepbound, which starts at $299 a month for the 2.5 mg starting dose, and ask my prescriber which dose is right after the switch.
Within 2 weeks: Have new compounded medication arriving, or be established on brand-name with a savings program locked in.

The key is to move fast and have a backup plan. Do not wait for your current pharmacy to “figure things out.” If they sent you a closure notice, they are done.

FAQ

Can I transfer my compounding prescription to a regular pharmacy?

A compounding prescription is written specifically for a compounded formulation, which means a retail pharmacy like CVS or Walgreens cannot fill it directly. Your provider would need to write a new prescription for a brand-name medication (Ozempic, Wegovy, Mounjaro, or Zepbound). The good news is that most providers can do this quickly since your medical history and treatment records already support the prescription.

How long can I go without my GLP-1 before I need to re-titrate?

It depends on the drug, so ask your prescriber before you restart. The Wegovy label says that if 2 or more consecutive weekly doses are missed, dose escalation should restart at a lower dose to reduce stomach and gut side effects. The Zepbound label says a missed dose can be taken within 4 days, and otherwise skipped. It does not give a rule for longer gaps, so your prescriber decides. Jumping back to a high dose after a long break can bring on severe nausea and vomiting.

Are any compounding pharmacies still making semaglutide in 2026?

Some telehealth platforms still sell compounded semaglutide made by 503A pharmacies for individual patients. 503B facilities cannot make it from bulk ingredient because semaglutide is not on the shortage list or the 503B bulks list. Availability varies, and supply can stop with little notice.

Is it safe to buy compounded GLP-1s from overseas pharmacies?

Buying from overseas pharmacies is risky and not recommended. These products are outside FDA oversight and may contain incorrect doses or impurities. The savings are not worth the safety risk. If cost is the main concern, look into manufacturer savings programs, FSA/HSA coverage, or patient assistance programs before considering overseas sources.

Will my insurance cover brand-name GLP-1 if my compounding pharmacy closes?

Insurance coverage for GLP-1 medications depends entirely on your plan, not on why you need the medication. If your plan covers Wegovy or Zepbound for weight management, you can get coverage regardless of your compounding history. If your plan does not cover weight loss medications, the pharmacy closure does not change that. Check our insurance coverage guide for strategies to get coverage approved, or explore GLP-1 without insurance options if your plan will not cover it.

What we checked

This AI-assisted public-source desk check reviewed the FDA’s compounding policy page, the FDA-approved Wegovy and Zepbound labels on DailyMed, and NovoCare Pharmacy and LillyDirect self-pay prices on November 4, 2026. This is not a clinical review and it is not medical advice. Prices and policies change, so confirm them with the provider or your prescriber before you act.

Guides:

Provider Reviews: Ro · Hims · MEDVi · Found · Calibrate

Compare: All Providers · Best GLP-1 Programs · All Guides